COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors
16/05/2018
Montrouge, France, May 16, 2018 DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage [...]
DBV Technologies annonce la nomination de Michel de Rosen à son Conseil d'administration
16/05/2018
Montrouge, France, le 16 mai (07h30 CEST) 2018 DBV Technologies annonce la nomination de Michel de Rosen à son Conseil d'administration DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth
16/05/2018
Full pipeline of late stage assets with blockbuster potential Positioned to deliver sales growth and margin expansion through 2022 Pipeline depth in key therapeutic areas and building new, distinctive platform [...]
Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
16/05/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis U.S. regulatory submission [...]
Sanofi : Résultats positifs de phase III pour Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère inadéquatement contrôlée de l'adolescent
16/05/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Résultats positifs de phase III pour Dupixent ® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère inadéquatement contrôlée de l' [...]
INNATE PHARMA : First quarter 2018 report
16/05/2018
first quarter 2018 report Cash, cash equivalents and financial assets of the Company amounted to €153.8 million [*] Significant momentum across the portfolio, with good progress on the joint monalizumab program with [...]
INNATE PHARMA : Information financière du premier trimestre 2018
16/05/2018
Information financiÈre du premier trimestre 2018 Trésorerie, équivalents de trésorerie et actifs financiers s'élevant à 153,8 millions d'euros [*] Progrès significatifs dans le portefeuille notamment pour monalizumab [...]
Idorsia initiates MODIFY, a Phase 3 registration study to assess lucerastat as a potential new treatment option for patients with Fabry disease
16/05/2018
Idorsia to host an investor webcast to discuss the Phase 3 program today at 14:00hrs CEST Allschwil, Switzerland - May 16, 2018 Idorsia Ltd (SIX: IDIA) today announced that the first patient has been enrolled in a [...]
Novartis announces changes to the Executive Committee
16/05/2018
Felix R. Ehrat, Group General Counsel, will retire on June 1, 2018 Shannon Thyme Klinger appointed to Group General Counsel Robert Weltevreden appointed Head of Novartis Business Services Basel, May 16, 2018 - Novartis [...]
Targovax to present at upcoming investor and industry conferences
16/05/2018
Oslo, Norway, 16 May 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present at the [...]
Assure Holdings Corp. Announces Appointment of New Auditor, New Executive Chairman and Interim Chief Executive Officer, New Role for Founder Preston Parsons, and Results of Forensic Audit
16/05/2018
PARKER, Colo., May 15, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSX-V: IOM ) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services announces the appointment of a new [...]
REVA Announces First Implants of the Fantom Bioresorbable Scaffold in Turkey
16/05/2018
SAN DIEGO, May 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced today launch of the Fantom [...]
Pacific Health Care Organization, Inc. Reports First Quarter 2018 Results
15/05/2018
NEWPORT BEACH, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly [...]
Veritas Pharma Has Retained Cannabis Branding Firm for Design of Label and Packaging
15/05/2018
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce with the dealer licence being granted which [...]
Synergy CHC Corp. Announces First Quarter 2018 Results
15/05/2018
Westbrook, Maine, May 15, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended March 31, 2018 [...]
Performance and Restricted Share Unit Plan Approved by IntelGenx Technologies Corp. Shareholders
15/05/2018
SAINT LAURENT, Quebec, May 15, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX ) (OTCQX:IGXT) (the “Company” or “IntelGenx”) confirms that the shareholders of the Company (the “Shareholders”) approved [...]
Solid Biosciences Announces Upcoming Preclinical Data Presentations
15/05/2018
CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) today announced that new preclinical data from its Duchenne muscular dystrophy (DMD) programs, including its lead gene transfer [...]
Cerner and Uniform Data System for Medical Rehabilitation Create Standardized Integration
15/05/2018
Collaboration will save clinicians time and reduce risk of errors KANSAS CITY, Mo., May 15, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, announced a collaborative agreement with Uniform [...]
Molecular Templates to Present at the UBS Global Healthcare Conference
15/05/2018
AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM ) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered [...]

Pages